Interview with Selwyn Kahanovitz, CEO, Litha Healthcare Group Limited
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
Address: 321 Main road, La Rocca,
Office Park, building D
Bryanston 2021,South Africa
Tel: 011 463 5733
Batswadi Pharmaceuticals (Pty) Ltd. operates as a clinical research company.
Batswadi was founded by CEO, Christopher Whitfield and Hennie Visser, Batswadi (meaning parent in Tswana) aims to increase Africa’s access to innovative products, diagnostics, devices and services.
Batswadi’s strategic partnerships with key stakeholders enable it to deliver economic benefits to its shareholders while simultaneously increasing African access to innovative products and technologies.
The management team has extensive experience in launching and marketing innovative products in the South African pharmaceutical market. Their experience in the evolution of the market provides deep understanding of critical developments expected into the future.
Batswadi specializes in clinical trials from phases II, III and IV.
The company focuses on four platforms: biotechnology, pharmaceuticals, diagnostics and clinical research. We further provide innovative medical companies with a presence in Africa, as well as the required infrastructure to launch their products on the continent.
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and anti-infectives produced locally. To what extent…
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and in those three years,…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as the General Manager of…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations.…
See our Cookie Privacy Policy Here
